MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics Investigated for Securities Fraud after 90% Stock DropContact BFA Law

Benzinga
2025.10.06 13:35

NEW YORK, Oct. 06, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into MoonLake Immunotherapeutics ( NASDAQ:MLTX ) for potential violations of the federal securities laws.

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.